Skip to main content
Ilaris - Important information for patients with Gouty Arthritis
For Healthcare Professionals
Patient alert card listing important information to consider before and during treatment with canakinumab for patients with Gouty Arthritis.
Back to top
Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Ilaris
Novartis Pharmaceuticals UK Ltd
For Healthcare Professionals
Ilaris - Important information for patients with Period Fever Syndromes
For Healthcare Professionals
Patient alert card listing important information to consider before and during treatment with canakinumab for patients with Periodic Fever Syndromes CAPS, TRAPS, HIDS/MKD or FMF.
Ilaris - Important information for the patient with Still's Disease (including Adult Onset Still's Disease) and Systemic Juvenile Idiopathic Arthritis
For Healthcare Professionals
Patient alert card listing important information to consider before and during treatment with canakinumab for patients with Still's Disease (including Adult Onset Still's Disease) and Systemic Juvenile Idiopathic Arthritis
You are trying to reach document intended for healthcare professionals only.
Are you a healthcare professional?
